Use in Special Populations Pediatric population: The safety and efficacy of Semaglut in children and adolescents below 18 years have not yet been established
3.3 Adverse Events and Other Safety Assessments The safety population comprised all 56 enrolled subjects who received semaglutide 0.5 mg
2026, doi: 10.1016/j.ebiom.2025.106119 Farokhnia, M., et al, "Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake," Journal of Clinical Investigation, March 6, 2025, doi: 10.1172/JCI188314 Petrie, G.N
When someone starts a GLP-1 medication, the first noticeable change is appetite
Similarly, there is no equivalent version of Mounjaro another popular weight loss medication
Key Points to Consider: Initial Phase: During the first few weeks on the medication, some patients may experience more significant weight loss (potentially exceeding 2 pounds per week), especially if they also adopt lifestyle changes such as dietary adjustments and increased physical activity